Not Yet Recruiting
Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS
NCT06925555
- Conditions
- Brentuximab Vedotin, Digestive System Diseases, EBV-Positive Diffuse Large B-Cell Lymphoma, Nos, +5 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China